NEU 6.41% $15.27 neuren pharmaceuticals limited

FDA approval does not transfer into Europe necessarily - the RoW...

  1. 2,640 Posts.
    lightbulb Created with Sketch. 427
    FDA approval does not transfer into Europe necessarily - the RoW buyer may have to run trials again to varying degrees - could be sign of due diligence happening
    Last edited by good1234: 17/02/23
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.